Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Waters Corporation, a developer of analytical science solutions, and the University of Warwick, Coventry and Warwickshire, England, have signed a collaborative research agreement intended to support the growth, development and adoption of novel mass spectrometry technologies, including Waters Synapt High Definition MS system.
Subscribe to our email newsletter
This agreement paves the way for research projects leading to meaningful impact for analysts using biomedical mass spectrometry (MS), validated by peer-reviewed publications, presentations at international conferences and an outreach education program, said Waters.
At the core of the collaborative agreement is the establishment of ‘The Waters Centre for BioMedical Mass Spectrometry’ at the University of Warwick. This center will offer scientists worldwide an accessible resource to enable the adoption of liquid chromatography/MS-based techniques in life science, added Waters.
Brian Smith, vice president of MS operations for the Waters division, said: “The University of Warwick is consistently ranked amongst the top research universities, with a historic track record in biological MS. However, this agreement is not based on reputation alone; it is based on a long-standing relationship with the university and professor James Scrivens in particular.
“Waters looks forward to taking this relationship to the next level through mutually beneficial research and an educational resource for life scientists adopting cutting edge MS-based research strategies.”